Different modes of intravenous serelaxin (recombinant human relaxin-2) administration enhance distinct endothelium-dependent vasodilator pathways in rat resistance arteries Abstract uri icon

authors

  • Leo, Chen
  • Ng, Hooi Hooi
  • Jelinic, Maria
  • O'Sullivan, Kelly
  • Tare, Marianne
  • Parry, Laura

publication date

  • January 1, 2014